BPMX Overview
Upcoming Projects (BPMX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BPMX)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (BPMX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BPMX)
-
BioPharmX Corporation (BPMX) aiming to begin phase 2/3 pivotal trial on BPX-01 for treating rosacea, in third quarter of 2017
Ticker: BPMX
Occurred on: Sep 12, 2017 -
BioPharmX Corporation (BPMX) looking to commence phase 3 trial on acne vulgaris treatment BPX-01 in 2017
Ticker: BPMX
Occurred on: Jun 01, 2017 -
BioPharmX Corporation (BPMX) set to release phase 2b study data on BPX-01, a drug treating acne vulgaris, in April or May of 2017
Ticker: BPMX
Occurred on: May 03, 2017 -
BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of Acne
Ticker: BPMX
Occurred on: Aug 24, 2016 -
BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks
Ticker: BPMX
Occurred on: Aug 22, 2016 -
BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the Skin
Ticker: BPMX
Occurred on: Jul 21, 2016
Strategic Initiatives (BPMX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
